Non-Invasive Plasma Treatment for Cervical Infections: Targeting High- and Low-Risk HPV Variants
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This is a prospective, single-center, observational proof-of-principle clinical trial at the Department of Women's Health of the University Hospital Tübingen.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Osoby w wieku 18 lat i starsze.
- •Stwierdzona obecność wirusa (HPV) w badaniu wymazu.
- •Widoczna strefa przejściowa szyjki macicy i zmiany odpowiadające wczesnym stadiom choroby.
- •Wyrażenie pisemnej zgody na udział w badaniu.
✗ Disqualifies
- •Strefa przejściowa szyjki macicy nie jest w pełni widoczna.
- •Wykrycie zaawansowanego stadium choroby (raka).
- •Poważne choroby serca i krążenia.
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- June 30, 2026
- Sex
- Female only
Therapies / drugs in trial
Locations (1)
University Hospital Tuebingen, Department of Women's Health
Tübingen, Germany
Trial contact
Martin Weiss, Dr. med.
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/3/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.